Section Arrow
SMTI.NASDAQ
- Sanara MedTech
Quotes are at least 15-min delayed:2026/11/05 04:09 EST
Pre Market
Last
 --
-- (--)
Bid
--
Ask
50.45
High -- 
Low -- 
Volume -- 
Regular Hours (Closed)
Last
 32.33
+0.16 (+0.50%)
Day High 
33.32 
Prev. Close
32.17 
1-M High
35.52 
Volume 
120.26K 
Bid
--
Ask
50.45
Day Low
31.54 
Open
33.32 
1-M Low
29.045 
Market Cap 
295.58M 
Currency 美元 
P/E 572.17 
%Yield -- 
10-SMA 32.72 
20-SMA 33.61 
50-SMA 34.42 
52-W High 35.52 
52-W Low 16.0465 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-3.72/0.16
Enterprise Value
343.42M
Balance Sheet
Book Value Per Share
0.86
Cash Flow
Cash Flow Yield
0.02
Income Statement
Total Revenue
45.84M
Operating Revenue Per Share
6.49
Industry Comparison
Code Name   Last Change Change (%) P/E P/E Range
MDLNMedline Inc40.35+6.26+18.36%42.65PE
Pre Market 40 -0.35 -0.87%
MMEDMiniMed Group, Inc.19.29+0.44+2.33%-- 
Pre Market -- -- --
BAXBaxter International26.5+1.01+3.96%-- 
Pre Market 26.54 +0.04 +0.15%
AVTRAvantor15.65+0.06+0.38%31.18PE
Pre Market 15.46 -0.19 -1.21%
WRBYWarby Parker21.29-0.65-2.96%365.67PE
Pre Market 21.3 +0.01 +0.05%
Industry overview quotes are at least 15 minutes delayed (Except Overnight Trading Session)
Business Description
Sanara MedTech Inc is a medical technology company focused on developing and commercializing technologies to improve clinical outcomes and reduce healthcare expenditures in the surgical market. It markets and sells soft tissue repair and bone fusion products for use in operating rooms and sterile environments. Its soft tissue repair products include CellerateRX Surgical Powder, a hydrolyzed collagen used in management of surgical wounds, and BIASURGE Surgical Solution, a sterile no-rinse solution for wound irrigation, while its bone fusion products include BiFORM Bioactive Moldable Matrix, an osteoconductive implant that supports bone growth, and ALLOCYTE Plus Viable Bone Matrix, a human allograft cellular bone matrix containing bone-derived progenitor cells and conformable bone fibers.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.